Chris Howerton

Stock Analyst at Jefferies

(2.62)
# 2,263
Out of 5,044 analysts
70
Total ratings
45.45%
Success rate
17.71%
Average return

Stocks Rated by Chris Howerton

Ardelyx
Jan 2, 2025
Maintains: Buy
Price Target: $11$8
Current: $5.11
Upside: +56.56%
Structure Therapeutics
Sep 29, 2023
Maintains: Buy
Price Target: $50$79
Current: $28.95
Upside: +172.88%
Milestone Pharmaceuticals
Jun 20, 2023
Downgrades: Hold
Price Target: $8$4
Current: $1.83
Upside: +118.58%
Veru Inc.
Jun 7, 2023
Upgrades: Hold
Price Target: $10
Current: $3.65
Upside: +173.97%
BioXcel Therapeutics
Mar 10, 2023
Downgrades: Hold
Price Target: $320$352
Current: $2.18
Upside: +16,046.79%
Avalo Therapeutics
Feb 8, 2023
Downgrades: Underperform
Price Target: $720
Current: $18.38
Upside: +3,817.30%
Compugen
Feb 8, 2023
Downgrades: Underperform
Price Target: $0.5
Current: $1.71
Upside: -70.76%
UroGen Pharma
Feb 8, 2023
Downgrades: Hold
Price Target: $35$10
Current: $20.18
Upside: -50.45%
Avadel Pharmaceuticals
Nov 30, 2022
Upgrades: Buy
Price Target: $6.5$11
Current: $18.59
Upside: -40.83%
Apellis Pharmaceuticals
Nov 10, 2022
Downgrades: Hold
Price Target: $70$40
Current: $30.05
Upside: +33.11%
Upgrades: Buy
Price Target: $57$61
Current: $29.64
Upside: +105.80%
Maintains: Buy
Price Target: $92$90
Current: $133.51
Upside: -32.59%
Downgrades: Hold
Price Target: $24$12
Current: $5.58
Upside: +115.05%
Initiates: Buy
Price Target: $20
Current: $0.90
Upside: +2,119.76%
Initiates: Buy
Price Target: $66
Current: $27.06
Upside: +143.90%
Initiates: Buy
Price Target: $22
Current: $5.60
Upside: +292.86%
Initiates: Buy
Price Target: $21
Current: $2.13
Upside: +885.92%
Initiates: Buy
Price Target: $22
Current: $1.62
Upside: +1,258.02%
Initiates: Buy
Price Target: $23
Current: $1.61
Upside: +1,333.02%
Downgrades: Hold
Price Target: $40$21
Current: $22.62
Upside: -7.16%
Upgrades: Buy
Price Target: $80$580
Current: $17.16
Upside: +3,279.95%
Downgrades: Underperform
Price Target: $63$60
Current: $1.25
Upside: +4,700.00%
Downgrades: Hold
Price Target: $16
Current: $71.56
Upside: -77.64%
Initiates: Buy
Price Target: $27
Current: $78.51
Upside: -65.61%
Initiates: Buy
Price Target: $1,200
Current: $5.94
Upside: +20,102.02%